Biological Products

"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.

Descriptor ID	D001688
MeSH Number(s)	D20.215
Concept/Terms	Biological Products Biological Products Biologic Products Products, Biologic Biologics Products, Biological Natural Products Natural Products Products, Natural

Below are MeSH descriptors whose meaning is more general than "Biological Products".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]

Below are MeSH descriptors whose meaning is related to "Biological Products".

Below are MeSH descriptors whose meaning is more specific than "Biological Products".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.

Bar chart showing 56 publications over 16 distinct years, with a maximum of 10 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	1	0	1
2008	2	1	3
2009	1	0	1
2010	1	2	3
2011	2	0	2
2012	3	0	3
2013	4	1	5
2015	3	0	3
2016	4	2	6
2017	3	0	3
2018	3	0	3
2019	3	1	4
2020	4	1	5
2021	2	0	2
2022	10	0	10
2023	2	0	2

Below are the most recent publications written about "Biological Products" by people in Profiles.

Vu M, Ghosh S, Umashankar K, Weber L, Landis C, Candela N, Chastek B. Comparison of surgery rates in biologic-na?ve patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN. BMC Gastroenterol. 2023 Mar 25; 23(1):87.

View in: PubMed
Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. J Pediatr Gastroenterol Nutr. 2023 May 01; 76(5):566-575.

View in: PubMed
Akenroye A, Zhou G, Jackson JW, Segal J, Alexander GC, Singh S. Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy. 2023 04; 78(4):1116-1119.

View in: PubMed
Ungaro RC, Chou B, Mo J, Ursos L, Twardowski R, Candela N, Colombel JF. Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA. J Crohns Colitis. 2022 Sep 08; 16(9):1405-1414.

View in: PubMed
Chari DA, Madhani A, Sharon JD, Lewis RF. Evidence for cognitive impairment in patients with vestibular disorders. J Neurol. 2022 Nov; 269(11):5831-5842.

View in: PubMed
Baker JF, Reed G, Poudel DR, Harrold LR, Kremer JM. Obesity and Response to Advanced Therapies in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022 Nov; 74(11):1909-1916.

View in: PubMed
Hsueh YC, Wang Y, Riding RL, Catalano DE, Lu YJ, Richmond JM, Siegel DL, Rusckowski M, Stanley JR, Harris JE. A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo. J Invest Dermatol. 2022 Dec; 142(12):3294-3303.

View in: PubMed
Patel D, Svoboda R, Maczuga S, Foulke GT, Helm M. A retrospective claims analysis confirms the cost of most biologic agents for psoriasis is increasing more rapidly than medical inflation. J Am Acad Dermatol. 2023 02; 88(2):490-493.

View in: PubMed
Rizzo A, Mollica V, Santoni M, Massari F. Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis. Clin Genitourin Cancer. 2022 10; 20(5):482-487.

View in: PubMed
Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):64-69.

View in: PubMed

People

Explore

Similar Concepts

Top Journals